BMJ 2001;322:139 ( 20 January )

Papers

Drug points

Hepatitis associated with Kava, a herbal remedy for anxiety

Monica EscherJules Desmeules

Division of Clinical Pharmacology and Toxicology

Emile Giostra

Division of Gastroenterology

Gilles Mentha

Division of Visceral Surgery, Geneva University Hospital, 1211 Geneva 14, Switzerland

Kava, the rhizome of the pepper plant Piper methysticum, has been widely used in the South Pacific as a narcotic drink. Lactones, the major constituents of kava, are considered to be pharmacologically active and are sold in Europe and the United States as standardised extracts for anxiety and tension.

A 50 year old man presented to his doctor because of jaundice. He had noticed fatigue for a month, a "tanned" skin, and dark urine. The medical history was unremarkable apart from slight anxiety, for which he had been taking three to four capsules of kava extracts daily for two months (maximum recommended dose three capsules) corresponding to a dose of 210-280 mg lactones (Laitain, Schwabe, Switzerland). He took no other drugs and did not consume alcohol. Liver function tests showed a 60-fold and 70-fold increase in aspartate aminotransferase and alanine aminotransferase concentrations, respectively. Alkaline phosphatase concentration was 430 IU/l (normal range 30-125), gamma -glutamyltransferase 691 IU/l (9-35), lactate dehydrogenase 1132 IU/l (125-240), and total and conjugated bilirubin 279.2 µmol/l (6.8-25) and 212.3 µmol/l (1.7-8.6), respectively. Prothrombin time was 25%. The patient was admitted to hospital. Ultrasonography showed a slight increase in liver size but no ascites or portal vein thrombosis. Blood tests for hepatitis A, B, C, and E, HIV, cytomegalovirus, and Epstein-Barr virus gave negative results. The patient's condition deteriorated within 48 hours. He developed stage IV encephalopathy and had to be intubated. Prothrombin time was then 10%. The patient received a liver transplant two days later. He recovered uneventfully. On examination the liver was atrophic, and the subhepatic and portal veins were free. Histology showed extensive and severe hepatocellular necrosis and extensive lobular and portal infiltration of lymphocytes and numerous eosinophils.

Heavy consumption of kava has been associated with increased concentrations of gamma -glutamyltransferase, suggesting potential hepatotoxicity.1 A case of recurring necrotising hepatitis has been reported.2 In our patient a relation between ingestion of kava and fulminant hepatic failure is supported by the chronology, histological findings, and exclusion of other causes of hepatitis. Assessment of causality according to the definitions of the World Health Organization is probable. Acute liver failure with a fatal outcome or that necessitates liver transplant has been attributed to various herbal preparations.3-5 This case illustrates the importance of inquiring about the use of over the counter health products. It was reported to the Swiss Pharmacovigilance Center in Berne.

Footnotes

   Competing interests: None declared.

References
1. Mathews JD, Riley MD, Fejo L, Munoz E, Milns N, Gardner ID, et al. Effects of the heavy usage of kava on physical health: summary of a pilot survey in an Aboriginal community. Med J Aust 1988; 148: 548-555[Medline].
2. Strahl S, Ehret V, Dahm HH, Maier KP. Necrotizing hepatitis after taking herbal medication. Dtsch Med Wschr 1998; 123: 1410-1414[Medline]. (In German.)
3. Mostefa-Kara N, Pauwels A, Pines E, Biour M, Levy VG. Fatal hepatitis after herbal tea. Lancet 1992; 340: 674[CrossRef][Medline].
4. Yoshida EM, McLean CA, Cheng ES, Blanc PD, Somberg KA, Ferrell LD, et al. Chinese herbal medicine, fulminant hepatitis, and liver transplantation. Am J Gastroenterol 1996; 91: 2647-2648[Medline].
5. Sheikh NM, Philen RM, Love LA. Chaparral-associated hepatotoxicity. Arch Intern Med 1997; 157: 913-919[Abstract].


© BMJ 2001

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Regulating herbal medicines in the UK
Robin E Ferner and Keith Beard
BMJ 2005 331: 62-63. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Ferner, R. E, Beard, K. (2005). Regulating herbal medicines in the UK. BMJ 331: 62-63 [Full text]  
  • Wheatley, D. (2005). Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. J Psychopharmacol 19: 414-421 [Abstract]  
  • Grabe, D. W, Garrison, G. D. (2004). Comparison of Natural Product Use Between Primary Care and Nephrology Patients. The Annals of Pharmacotherapy 38: 1169-1172 [Abstract] [Full text]  
  • Sparreboom, A., Cox, M. C., Acharya, M. R., Figg, W. D. (2004). Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents. JCO 22: 2489-2503 [Abstract] [Full text]  
  • Yuan, C.-S., Mehendale, S., Xiao, Y., Aung, H. H., Xie, J.-T., Ang-Lee, M. K. (2004). The Gamma-Aminobutyric Acidergic Effects of Valerian and Valerenic Acid on Rat Brainstem Neuronal Activity. Anesth. Analg. 98: 353-358 [Abstract] [Full text]  
  • Desai, A. K., Grossberg, G. T. (2003). Herbals and Botanicals in Geriatric Psychiatry. AJGP 11: 498-506 [Abstract] [Full text]  
  • (2003). Hepatic Toxicity Possibly Associated With Kava-Containing Products--United States, Germany, and Switzerland, 1999-2002. JAMA 289: 36-37 [Full text]  
  • De Smet, P. A.G.M. (2002). Herbal Remedies. NEJM 347: 2046-2056 [Full text]  
  • Valli, G., Giardina, E.-G. V. (2002). Benefits, adverse effects and drug interactionsof herbal therapies with cardiovascular effects. J Am Coll Cardiol 39: 1083-1095 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Hepatotoxicity of medicinal plants
F Firenzuoli, et al.
bmj.com, 25 Jan 2001 [Full text]
Kava and Benzodiazepines-worsening withdrawal
Aidan Cartledge, et al.
bmj.com, 31 Aug 2001 [Full text]
Are Standardised Extracts Truly Herbal Medicine?
Peter Whitton
bmj.com, 7 Mar 2001 [Full text]
kava and gamma-glutamyltransferaseincrease: hepatic enzymatic induction or liver function alteration
Barguil
bmj.com, 21 Mar 2001 [Full text]
False assumption
Ron Law
bmj.com, 21 Nov 2003 [Full text]



Student BMJ

Intimate examinations

Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.

www.student.bmj.com

Listen to the latest BMJ Interview